Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02339987 · ClinicalTrials.gov registry record

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

A clinical trial, sponsored by Saint John's Cancer Institute.

Terminated
Registry status
27
Enrollment target

NCT02339987 is a clinical trial that was terminated before completion, run by Saint John's Cancer Institute. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02339987 was terminated before completion, sponsored by Saint John's Cancer Institute.

TERMINATED
Registry status
27 participants
Enrollment target

Study Summary

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2014-11
Est. Completion 2018-06-04

Sponsor

Saint John's Cancer Institute

19 total trials

What the Registry Record Tells You About NCT02339987

The ClinicalTrials.gov registry entry for NCT02339987 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint John's Cancer Institute, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02339987 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02339987 about?

NCT02339987 is a clinical study titled "Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration". Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

What is the current status of trial NCT02339987?

This trial is currently terminated. The enrollment target is 27 participants. The study started on 2014-11. Estimated completion is 2018-06-04.

Who is sponsoring clinical trial NCT02339987?

This trial is sponsored by Saint John's Cancer Institute, which has 19 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.